Benign Phyllodes Tumor and Ductal Carcinoma in Situ Coexist in the Same Breast Tumor: A Case Report and Review of the Literature

Shaohua Qu,Chiseng Lei,Jiamei Hu,Yuan Li,Yude Xie,Jie Zhang,Ningxia Wang,Yuhua Ma
DOI: https://doi.org/10.31487/j.scr.2022.11.05
2022-01-01
Surgical Case Reports
Abstract:Background: Breast phyllodes tumor (PT), the rare fibroepithelial mammary tumor is composed by mesenchymal and epithelial components, only 1%~2% of which were accompanied by epithelial breast cancer. The incidence of non-invasive ductal carcinoma (DCIS) arising in benign PTs is even rarer. There is no certain treatment for it currently because of the low incidence of PT with DCIS. Case Description: Here, we report a 57-year-old female patient who was diagnosed with ductal carcinoma in situ arising in a benign phyllodes tumor of the breast. Mastectomy and sentinel lymph nodes biopsy were performed, and endocrine therapy was administrated to the patient. No recurrence was noted during follow-up. Conclusion: Since PTs are prone to recurrence, adjuvant therapy should be considered comprehensively by the histopathological results after surgical treatment. In addition, regular follow-up is recommended.
What problem does this paper attempt to address?